Sign in

CIK 0001374690

  • Non-accelerated filer
  • Smaller reporting company

Larimar Therapeutics, Inc.

Sign in to watch
Ticker
LRMR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
203857670
Phone
+1 844-511-9056
Business address
THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA, 19004
Former names
ZAFGEN, INC., ZAFGEN INC
  1. 4 Open-market buy President and CEO bought 10,000 shares at $3.00 ($29,987)
  2. 4 Open-market sale 10% owner sold 1,341,499 shares at $3.31 ($4,442,776)
  3. 4 Open-market buy President and CEO bought 5,000 shares at $3.02 ($15,104)
  4. 4 Open-market buy Chief Financial Officer bought 16,000 shares at an average $3.12 ($49,862)
  5. 4 Open-market buy Director bought 10,000 shares at $2.99 ($29,900)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Grant or award Director acquired 5,564 shares (grant or award)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Returned to the company Director returned 4,424 shares (to the company)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 10 of 14 · 273 filings